(NASDAQ: BPAX) today announced the appointment of Jeffrey W.

Winkelman, Ph.D., J.D.

as vice president, oncology programs.

His primary responsibilities will be management of BioSante?s...

Patent and Trademark Office (USPTO) issued today patent 7,635,479, "Compositions and Method...Findings offer potential significance to the recovery of walking...

(Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the Soutschek and Manoharan patent (Application No....

The Delhi High Court has put an end to the trend among pharmaceutical companies to take patent litigation directly to court without first approaching the Intellectual Property Appellate...

(NASDAQ: BPAX) today announced the appointment of Jeffrey W.

Winkelman, Ph.

D., J.D.

as vice president, oncology programs.

His primary responsibilities will be management of BioSante's oncology products including...

( NASDAQ:BPAX) today announced the appointment of Jeffrey W.

Winkelman, Ph.

D., J.D.

as vice president, oncology programs.

His primary responsibilities will be management of BioSante's oncology products including...

(NASDAQ: BPAX) today announced the appointment of Jeffrey W.

Winkelman, Ph.

D., J.D.

as vice president, oncology programs.

His primary responsibilities will be management of BioSantes oncology products including...

- (BUSINESS WIRE) - BioSante Pharmaceuticals, Inc.

(NASDAQ: BPAX) today announced the appointment of Jeffrey W.

Winkelman, Ph.D., J.D.

as vice president, oncology programs.

His primary responsibilities will be management of BioSante...

(NASDAQ: BPAX) today announced the appointment of Jeffrey W.

Winkelman, Ph.D., J.D.

as vice president, oncology programs.

His primary responsibilities will be management of BioSante's oncology products including...

LINCOLNSHIRE, Ill.

-- (BUSINESS WIRE) -- BioSante Pharmaceuticals, Inc.

(NASDAQ: BPAX) today announced the appointment of Jeffrey W.

Winkelman, Ph.

D., J.D.

as vice president,...

Category : Press Release News Alerts by Email ( click here ) Press Release News | Home LINCOLNSHIRE, Ill.

- (Business Wire) BioSante Pharmaceuticals, Inc.

(NASDAQ: BPAX) today announced the appointment of Jeffrey W....

Known as...

About Transcept is a specialty pharmaceutical company focused on...

9, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc.

, a leading manufacturer of respiratory medical devices, recently announced today that the company was granted approval of the Stage-I audit conducted by BSI America, Inc.

on...

The acquisition integrates the patent...

SAN FRANCISCO, CA -- (Marketwire) -- 02/09/10 -- Cardiac Network, Inc.

(PINKSHEETS: CNWI) confirmed today that it has begun executing the terms under a binding Letter of Intent, or LOI, signed with...

('SCT' or the 'Company') (TSX VENTURE: SSS) announced today it has been advised by the Data Safety Monitoring Board ('DSMB') that its third and final regularly scheduled safety analysis has been completed and the DSMB...

("SCT" or the "Company") (TSX VENTURE: SSS) announced today it has been advised by the Data Safety Monitoring Board ("DSMB") that its third and final regularly scheduled safety analysis has been...

(Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the Soutschek and Manoharan patent (Application No....

(Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the Soutschek and...